What is Sharma East India Hospitals & Medical Research share price return in the past 10 years?

Data is not available for this company

What is the share price of Sharma East India Hospitals & Medical Research?

Company share prices are keep on changing according to the market conditions. The closing price of Sharma East India Hospitals & Medical Research on 20-Dec-2024 at 16:59 is 80.28.

What is the P/E ratio of Sharma East India Hospitals & Medical Research?

The latest standalone P/E ratio of Sharma East India Hospitals & Medical Research as of 20-Dec-2024 is 30.48.

What is the P/B ratio of Sharma East India Hospitals & Medical Research?

The latest standalone P/B ratio of Sharma East India Hospitals & Medical Research as of 20-Dec-2024 is 2.41.

What is the 52-week high and low of Sharma East India Hospitals & Medical Research?

The 52-week high of Sharma East India Hospitals & Medical Research is Rs. 120.80 and the 52-week low is Rs. 22.50.

What is the TTM revenue of Sharma East India Hospitals & Medical Research?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sharma East India Hospitals & Medical Research is Rs. 23.39 (Cr.).

Sharma East India Hospitals & Medical Research Ltd - Stock Valuation and Financial Performance

Name: Sharma East India Hospitals & Medical Research
Brand: Sharma East India Hospitals & Medical Research

BSE: 524548 | NSE: | Hospital & Healthcare Services | Small Cap

Place order

Sharma Hospitals Share Price

₹80.28 1.57 1.99%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Sharma Hospitals

Based on:

Data

M-Cap below 100cr DeciZen not available

Sharma East India Hospitals & Medical Research stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

30.48

Market Cap:

26.4 Cr.

52-wk low:

22.5

52-wk high:

120.8

Is Sharma East India Hospitals & Medical Research Ltd an attractive stock to invest in?

1. Is Sharma East India Hospitals & Medical Research Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sharma East India Hospitals & Medical Research Ltd is a below average quality company.

2. Is Sharma East India Hospitals & Medical Research Ltd undervalued or overvalued?

The key valuation ratios of Sharma East India Hospitals & Medical Research Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Sharma East India Hospitals & Medical Research Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sharma East India Hospitals & Medical Research Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sharma Hospitals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	9%	4.2%	8.7%	6.5%	7.7%	8.9%	10%	10.6%	12%	11.1%	-
Value Creation Index ⓘ	-0.4	-0.7	-0.4	-0.5	-0.5	-0.4	-0.3	-0.2	-0.1	-0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	16.4	17.2	17.1	16	14.7	16.2	8.1	17	20.7	18.5	23
Sales YoY Gr.	-	5.2%	-0.4%	-6.7%	-7.9%	9.8%	-49.7%	109.6%	21.7%	-10.7%	-
Adj EPS ⓘ	1.7	0.1	0.3	0.4	-1.3	0.9	-4	2.1	2.5	-9.1	2.6
YoY Gr.	-	-94.8%	177.8%	56%	-430.8%	NA	-530.1%	NA	22.7%	-458.7%	-
BVPS (₹) ⓘ	15.6	15.7	20.1	20.5	21.4	22.5	24.5	26.6	29.5	31.5	33.3
Adj Net Profit ⓘ	0.6	0	0.1	0.1	-0.4	0.3	-1.3	0.7	0.8	-3	1
Cash Flow from Ops. ⓘ	-0.2	-0.1	0.8	3.1	-1.4	1.2	1.4	2	1.3	-1.1	-
Debt/CF from Ops. ⓘ	-30.2	-47.4	9.2	1.7	-7.6	6.1	4.3	2.1	6.5	-4.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	1.4%	4.7%	31.6%	-10.7%
Adj EPS ⓘ	-220.2%	NA	NA	-458.7%
BVPSⓘ	8.1%	8.1%	8.9%	6.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	8.9	0.5	1.2	1.7	-5.5	3.8	-15.3	7.4	8.3	-27.5	8.1
Op. Profit Mgn % ⓘ	7.6	5.1	9.5	9.1	4.3	11.9	-8.1	13.2	15.9	-10.1	-6.2
Net Profit Mgn % ⓘ	3.5	0.2	0.5	0.8	-2.9	1.9	-16.2	4	4	-16.2	3.7
Debt to Equity ⓘ	1	1.1	1	0.7	1.4	0.9	0.7	0.5	0.8	0.5	0.1
Working Cap Days ⓘ	157	170	192	201	227	246	470	207	193	264	136
Cash Conv. Cycle ⓘ	16	35	43	52	71	73	128	17	2	4	-64

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 8.10%

Sales growth is growing at healthy rate in last 3 years 31.58%

Debt to equity has declined versus last 3 years average to 0.45

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 8.33%

Latest Financials - Sharma East India Hospitals & Medical Research Ltd.

	Standalone	Consolidated
TTM EPS (₹)	2.6	-
TTM Sales (₹ Cr.)	23.4	-
BVPS (₹.) ⓘ	33.3	-
Reserves (₹ Cr.) ⓘ	8	-
P/BV ⓘ	2.41	-
PE ⓘ	30.48	-

From the Market
52 Week Low / High (₹)	22.50 / 120.80
All Time Low / High (₹)	22.50 / 120.80
Market Cap (₹ Cr.)	26.4
Equity (₹ Cr.)	3.3
Face Value (₹)	10
Industry PE ⓘ	43.2

Management X-Ray of Sharma Hospitals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sharma Hospitals

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Sharma Hospitals

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	16.36	17.21	17.14	16	14.73	16.17	8.13	17.04	20.73	18.52
Operating Expenses ⓘ	15.12	16.33	15.51	14.54	14.09	14.24	8.79	14.78	17.43	20.40
Manufacturing Costs	6	7.36	10.45	9.70	9.49	8.82	4.50	9.01	10.06	11.91
Material Costs	2.82	3.24	0.02	0.02	0.10	2	0.98	3.46	4.58	5.05
Employee Cost	5.24	4.34	3.35	2.57	2.53	3.06	1.81	1.88	2.13	2.60
Other Costs ⓘ	1.06	1.39	1.69	2.26	1.98	0.37	1.50	0.43	0.67	0.84
Operating Profit ⓘ	1.24	0.88	1.63	1.46	0.64	1.93	-0.66	2.26	3.30	-1.88
Operating Profit Margin (%)	7.6%	5.1%	9.5%	9.1%	4.3%	11.9%	-8.1%	13.2%	15.9%	-10.1%
Other Income ⓘ	0.55	0.22	0.26	0.07	1.11	0.03	2.83	0.06	0.06	5.31
Interest ⓘ	0.76	0.48	1.08	0.73	0.88	1.15	0.69	0.70	1.18	0.95
Depreciation ⓘ	0.61	0.59	0.70	0.62	0.52	0.43	0.65	0.78	1.39	1.48
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.43	0.04	0.11	0.18	0.34	0.38	0.84	0.83	0.79	1
Tax ⓘ	-0.14	0.01	0.03	0.05	0.08	0.07	0.20	0.15	-0.04	0.34
Profit After Tax	0.57	0.03	0.08	0.13	0.27	0.31	0.64	0.68	0.83	0.66
PAT Margin (%)	3.5%	0.2%	0.5%	0.8%	1.8%	1.9%	7.8%	4.0%	4.0%	3.6%
Adjusted EPS (₹)	1.7	0.1	0.3	0.4	0.8	0.9	1.9	2.1	2.5	2.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	6.19	6.20	7.48	7.61	7.89	8.28	8.92	9.60	10.57	11.23
Share Capital ⓘ	4.16	4.16	4.16	4.16	4.16	4.16	4.16	4.16	4.16	4.16
Reserves ⓘ	2.03	2.05	3.32	3.46	3.73	4.12	4.76	5.44	6.41	7.07
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	5.83	6.11	7.06	4.93	10.49	6.90	5.44	4.10	7.97	4.59
Long Term Debt	5.83	1.72	1.66	0.81	0.56	1.60	1.35	1.33	1.63	1.17
Short Term Debt	0	4.39	5.40	4.12	9.93	5.30	4.09	2.77	6.34	3.42
Trade Payables	1.07	1.07	0.92	0.93	1.04	1.57	1.24	3.64	3.80	5
Others Liabilities ⓘ	1.42	1.98	2.18	2.82	2.72	3.11	3.28	1.72	1.37	4.35
Total Liabilities ⓘ	14.52	15.36	17.64	16.29	22.13	19.86	18.87	19.06	23.71	25.17
Fixed Assets
Gross Block	14.18	13.69	7.09	7.38	6.49	6.60	8.34	10.46	14.10	13.92
Accumulated Depreciation	7.60	7.69	0.69	1.31	1.76	2.19	2.83	3.61	5	6.23
Net Fixed Assetsⓘ	6.58	6.01	6.40	6.07	4.73	4.41	5.51	6.85	9.10	7.70
CWIP ⓘ	0	0	0	0.01	0.35	1.74	0	0	0	0
Investmentsⓘ	0.31	0.31	1.79	1.79	1.80	1.89	1.89	1.89	2.05	2.05
Inventories	0.13	0.65	0.62	0.64	0.62	0.62	0.56	0.46	0.52	0.68
Trade Receivables	2.09	2.72	2.32	3.25	3.45	4.75	2.68	3.39	4.29	2.58
Cash Equivalents	0.11	0.15	0.12	0.18	5.15	0.13	2.21	0.27	0.69	0.51
Others Assetsⓘ	5.30	5.52	6.40	4.35	6.04	6.32	6.02	6.20	7.08	11.64
Total Assets ⓘ	14.52	15.36	17.64	16.29	22.13	19.86	18.87	19.06	23.71	25.17

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-0.20	-0.14	0.82	3.12	-1.43	1.21	1.40	2.03	1.28	-1.13
PBT ⓘ	0.43	0.04	0.11	0.18	0.34	0.38	0.84	0.83	0.79	1
Adjustment ⓘ	1.35	1	1.80	1.31	0.30	1.57	-1.38	1.48	2.43	-2.66
Changes in Working Capital ⓘ	-1.86	-1.15	-1.04	1.68	-2.01	-0.68	2.07	-0.14	-1.95	0.82
Tax Paid ⓘ	-0.13	-0.02	-0.05	-0.06	-0.07	-0.06	-0.13	-0.14	0	-0.29
Cash Flow From Investing Activity ⓘ	-0.02	-0.01	-0.77	-0.25	1.65	-1.50	2.79	-2.11	-3.63	5.17
Capex	-0.50	-0.04	-0.77	-0.26	1.65	-1.50	2.79	-2.12	-3.64	5.14
Net Investments	0.48	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.03	0	0	0	0	0	0.01	0.01	0.02
Cash Flow From Financing Activityⓘ	-0.81	0.19	-0.08	-2.80	4.74	-4.74	-2.16	-1.78	2.77	-4.20
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.06	0	-0.06	-0.85	-0.26	1.04	-0.26	0.24	0.30	-0.46
Interest Paid ⓘ	-0.75	-0.45	-1.03	-0.67	-0.81	-1.15	-0.69	-0.70	-1.18	-0.95
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.63	1.01	-1.28	5.81	-4.63	-1.21	-1.32	3.65	-2.80
Net Cash Flow ⓘ	-1.03	0.05	-0.03	0.06	4.96	-5.03	2.03	-1.86	0.41	-0.17

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	10.55	0.58	1.43	1.98	3.87	4.25	8.27	8.12	9.06	6.61
ROCE (%)	9.01	4.21	8.7	6.52	7.7	8.88	10.01	10.64	12.03	11.1
Asset Turnover Ratio	1.06	1.15	1.04	0.94	0.77	0.77	0.42	0.9	0.97	0.76
PAT to CFO Conversion(x)	-0.35	-4.67	10.25	24	-5.3	3.9	2.19	2.99	1.54	-1.71
Working Capital Days
Receivable Days	36	51	54	64	83	93	167	65	68	68
Inventory Days	3	8	13	14	16	14	26	11	9	12
Payable Days	119	120	0	0	3,539	239	526	257	297	318

Sharma East India Hospitals & Medical Research Ltd Stock News

Sharma East India Hospitals & Medical Research Ltd FAQs

What is the share price of Sharma Hospitals?

Company share prices are keep on changing according to the market conditions. The closing price of Sharma Hospitals on 20-Dec-2024 16:59 is ₹80.28.

What is the market cap of Sharma Hospitals?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Sharma Hospitals stood at ₹26.36.

What is the P/E ratio of Sharma Hospitals?

The latest P/E ratio of Sharma Hospitals as of 20-Dec-2024 16:59 is 30.48.

What is the P/B ratio of Sharma Hospitals?

The latest P/B ratio of Sharma Hospitals as of 20-Dec-2024 16:59 is 2.41.

What is the 52-week high and low of Sharma Hospitals?

The 52-week high of Sharma Hospitals is ₹120.8 and the 52-week low is ₹22.50.

What is the TTM revenue of Sharma Hospitals?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sharma Hospitals is ₹23.39 ( Cr.) .

About Sharma East India Hospitals & Medical Research Ltd

Sharma East India Hospitals & Medical Research Limited is a public limited company incorporated in India in 1989 having its registered office at Jaipur, Rajasthan. The company is primarily engaged in the business of providing medical and healthcare services and real estate services and is running a multi-specialty hospital in the name and style of Jaipur Hospital at Lal Kothi, Jaipur, Rajasthan.

The company is predominantly engaged in service activities related with the Medical & Health Sciences. The demand for sophisticated modern healthcare facilities is expanding very fast. With the ever-expansive field of Medical Science and research the cult of health consciousness is spreading rapidly. The company aims at providing wide range of medical services in the field of Health Industry. The objective is to offer best quality services to its customers at low costs and to achieve health growth and profitability. The company is committed to achieve its objective while ensuring high levels of ethical standards, professional integrity and regulatory compliances.

Business area of the company

The company is primarily engaged in the business of providing medical and healthcare services and real estate services and is running a multi-specialty hospital.